Have a personal or library account? Click to login

BK virus: microbiology, epidemiology, pathogenesis, clinical manifestations and treatment

Open Access
|Apr 2018

References

  1. 1. Carbone M, Rizzo P, Grimley PM, Procopio A, Mew DJ, Shridhar V, et al. Simian virus-40 large-T antigen binds p53 in human mesotheliomas. Nat Med. 1997; 3: 908-12.10.1038/nm0897-908
  2. 2. Agostini HT, Ryschkewitsch CF, Brubaker GR, Shao J, Stoner GI. Five complete genomes of JC virus type 3 from Africans and African Americans. Arch Virol. 1997; 142:637-55.10.1007/s007050050108
  3. 3. Chatterjee M, Weyandt TB, Frisque RJ. Identification of archetype and rearranged forms of BK virus in leukocytes from healthy individuals. J Med Virol. 2000; 60:353-62.10.1002/(SICI)1096-9071(200003)60:3<;353::AID-JMV16>3.0.CO;2-R
  4. 4. Purighalla R, Shapiro R, McCauley J, Randhawa P. BK virus infection in a kidney allograft diagnosed by needle biopsy. Am J Kidney Dis. 1995; 26:671-3. 10.1016/0272-6386(95)90608-8
  5. 5. Arthur RR, Shah KV, Baust SJ, Santos GW, Saral R. Association of BK viruria with hemorrhagic cystitis in recipients of bone marrow transplants. N Engl J Med. 1986; 315:230-4.10.1056/NEJM198607243150405
  6. 6. Astrom K. Progressive multifocal leukoencephalopathy: the discovery of a neurologic disease. In: K Khalili GS, editor. Human polyomaviruses: molecular and clinical perspectives New York:Wiley-Liss; 2001. p. 1-10.10.1002/0471221945.ch1
  7. 7. Harris KF, Chang E, Christensen JB, Imperiale MJ. BK virus as a potential co-factor in human cancer. Dev Biol Stand. 1998; 94:81-91.
  8. 8. Knowles W. The epidemiology of BK virus and the occurence of antigenic and genomic subtypes. In: K Khalili GS, editor. Human polyomaviruses: molecular and clinical perspectives: New York:Wiley-Liss; 2001. p. 527-60.10.1002/0471221945.ch19
  9. 9. Arthur RR, Shah KV. Occurrence and significance of papovaviruses BK and JC in the urine. Prog Med Virol. 1989; 36:42-61.
  10. 10. Hirsch HH, Brennan DC, Drachenberg CB, Ginevri F, Gordon J, Limaye AP, et al. Polyomavirus-associated nephropathy in renal transplantation: interdisciplinary analyses and recommendations. Transplantation. 2005; 79:1277-86.10.1097/01.TP.0000156165.83160.09
  11. 11. Goudsmit J, Wertheim-van Dillen P, van Strien A, van der Noordaa J. The role of BK virus in acute respiratory tract disease and the presence of BKV DNA in tonsils. J Med Virol. 1982; 10:91-9.10.1002/jmv.1890100203
  12. 12. Voltz R, Jager G, Seelos K, Fuhry L, Hohlfeld R. BK virus encephalitis in an immunocompetent patient. Arch Neurol. 1996; 53:101-3.10.1001/archneur.1996.00550010121025
  13. 13. de Silva LM, Bale P, de Courcy J, Brown D, Knowles W. Renal failure due to BK virus infection in an immunodeficient child. J Med Virol. 1995; 45:192-6. 10.1002/jmv.1890450214
  14. 14. Leung AY, Chan M, Tang SC, Liang R, Kwong YL. Real-time quantitative analysis of polyoma BK viremia and viruria in renal allograft recipients. J Virol Methods. 2002; 103:51-6.10.1016/S0166-0934(01)00447-5
  15. 15. Hirsch HH, Knowles W, Dickenmann M, Passweg J, Klimkait T, Mihatsch MJ, et al. Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients. N Engl J Med. 2002; 347:488-96.10.1056/NEJMoa020439
  16. 16. Kitamura T, Satoh K, Tominaga T, Taguchi F, Tajima A, Suzuki K, et al. Alteration in the JC polyomavirus genome is enhanced in immunosuppressed renal transplant patients. Virology. 1994; 198:341-5.10.1006/viro.1994.1038
  17. 17. Del Valle L, Croul S, Morgello S, Amini S, Rappaport J, Khalili K. Detection of HIV-1 Tat and JCV capsid protein, VP1, in AIDS brain with progressive multifocal leukoencephalopathy. J Neurovirol. 2000; 6:221-8.10.3109/13550280009015824
  18. 18. Geetha D, Tong BC, Racusen L, Markowitz JS, Westra WH. Bladder carcinoma in a transplant recipient: evidence to implicate the BK human polyomavirus as a causal transforming agent. Transplantation. 2002; 73:1933-6.10.1097/00007890-200206270-00015
  19. 19. Frisque RJ WF. The Molecular Biology of JC Virus, Causative Agent of Progressive Multifocal Leukoencephalopathy. Totowa:Humana Press; 1992. 10.1007/978-1-4612-0407-7_2
  20. 20. Behzad-Behbahani A, Klapper PE, Vallely PJ, Cleator GM. BK virus DNA in CSF of immunocompetent and mmunocompromised patients. Arch Dis Child. 2003; 88:174-5.10.1136/adc.88.2.174
  21. 21. Coleman DV, Mackenzie EF, Gardner SD, Poulding JM, Amer B, Russell WJ. Human polyomavirus (BK) infection and ureteric stenosis in renal allograft recipients. J Clin Pathol. 1978; 31:338-47.10.1136/jcp.31.4.338
  22. 22. Mathur VS, Olson JL, Darragh TM, Yen TS. Polyomavirus-induced interstitial nephritis in two renal transplant recipients: case reports and review of the literature. Am J Kidney Dis. 1997; 29:754-8.10.1016/S0272-6386(97)90130-X
  23. 23. Nickeleit V, Hirsch HH, Binet IF, Gudat F, Prince O, Dalquen P, et al. Polyomavirus infection of renal allograft recipients: from latent infection to manifest disease. J Am Soc Nephrol. 1999;10:1080-9.10.1681/ASN.V1051080
  24. 24. Hirsch HH. BK virus: opportunity makes a pathogen. Clin Infect Dis. 2005; 41:354-60.10.1086/431488
  25. 25. Nickeleit V, Hirsch HH, Zeiler M, Gudat F, Prince O, Thiel G, et al. BK-virus nephropathy in renal transplants-tubular necrosis, MHC-class II expression and rejection in a puzzling game. Nephrol Dial Transplant. 2000;15:324-32.10.1093/ndt/15.3.324
  26. 26. Hirsch HH. Polyomavirus BK nephropathy: a (re-) emerging complication in renal transplantation. Am J Transplant. 2002;2:25-30.10.1034/j.1600-6143.2002.020106.x
  27. 27. Ramos E, Drachenberg CB, Papadimitriou JC, Hamze O, Fink JC, Klassen DK, et al. Clinical course of polyoma virus nephropathy in 67 renal transplant patients. J Am Soc Nephrol. 2002;13:2145-51.10.1097/01.ASN.0000023435.07320.81
  28. 28. Hirsch HH, Steiger J. Polyomavirus BK. Lancet Infect Dis. 2003; 3:611-23.10.1016/S1473-3099(03)00770-9
  29. 29. Sachdeva MS, Nada R, Jha V, Sakhuja V, Joshi K. The high incidence of BK polyoma virus infection among renal transplant recipients in India. Transplantation. 2004; 77:429-31.10.1097/01.TP.0000113163.02039.3014966420
  30. 30. Howell DN, Smith SR, Butterly DW, Klassen PS, Krigman HR, Burchette JL Jr, et al. Diagnosis and management of BK polyomavirus interstitial nephritis in renal transplant recipients. Transplantation. 1999; 68:1279-88.10.1097/00007890-199911150-0001110573064
  31. 31. Binet I, Nickeleit V, Hirsch HH, Prince O, Dalquen P, Gudat F, et al. Polyomavirus disease under new immunosuppressive drugs: a cause of renal graft dysfunction and graft loss. Transplantation. 1999; 67: 918-22.10.1097/00007890-199903270-0002210199744
  32. 32. Nickeleit V, Singh HK, Mihatsch MJ. Polyomavirus nephropathy: morphology, pathophysiology, and clinical management. Curr Opin Nephrol Hypertens. 2003; 12:599-605.10.1097/00041552-200311000-0000514564196
  33. 33. Dorries K. Molecular biology and pathogenesis of human polyomavirus infections. Dev Biol Stand. 1998; 94:71-9.
  34. 34. Petrogiannis-Haliotis T, Sakoulas G, Kirby J, Koralnik IJ, Dvorak AM, Monahan-Earley R, et al. BK-related polyomavirus vasculopathy in a renal-transplant recipient. N Engl J Med. 2001; 345:1250-5.10.1056/NEJMoa010319
  35. 35. Karam G, Maillet F, Parant S, Soulillou JP, Giral-Classe M. Ureteral necrosis after kidney transplantation: risk factors and impact on graft and patient survival. Transplantation. 2004; 78:725-9.10.1097/01.TP.0000131953.13414.99
  36. 36. Hogan TF, Borden EC, McBain JA, Padgett BL, Walker DL. Human polyomavirus infections with JC virus and BK virus in renal transplant patients. Ann Intern Med. 1980; 92:373-8.10.7326/0003-4819-92-3-373
  37. 37. Hurault de Ligny B, Etienne I, Francois A, Toupance O, Buchler M, Touchard G, et al. Polyomavirus-induced acute tubulo-interstitial nephritis in renal allograft recipients. Transplant Proc. 2000; 32:2760-1.10.1016/S0041-1345(00)01869-8
  38. 38. Etienne I, Francois A, Redonnet M, Mouton-Schleifer D, Guerrier V, Janvresse C, et al. Does polyomavirus infection induce renal failure in cardiac transplant recipients? Transplant Proc. 2000; 32:2794-5.10.1016/S0041-1345(00)01889-3
  39. 39. Puliyanda DP, Amet N, Dhawan A, Hilo L, Radha RK, Bunnapradist S, et al. Isolated heart and liver transplant recipients are at low risk for polyomavirus BKV nephropathy. Clin Transplant. 2006; 20:289-94.10.1111/j.1399-0012.2005.00480.x16824143
  40. 40. Akiyama H, Kurosu T, Sakashita C, Inoue T, Mori S, Ohashi K, et al. Adenovirus is a key pathogen in hemorrhagic cystitis associated with bone marrow transplantation. Clin Infect Dis. 2001; 32:1325-30.10.1086/31999211303268
  41. 41. Shields AF, Hackman RC, Fife KH, Corey L, Meyers JD. Adenovirus infections in patients undergoing bone-marrow transplantation. N Engl J Med. 1985; 312:529-33.10.1056/NEJM1985022831209012982098
  42. 42. Binet I, Nickeleit V, Hirsch HH. Polyomavirus infections in transplant recipients. Current Opinion in Organ Transplantation. 2000; 5:210-6.10.1097/00075200-200009000-00007
  43. 43. Leung AY, Mak R, Lie AK, Yuen KY, Cheng VC, Liang R, et al. Clinicopathological features and risk factors of clinically overt haemorrhagic cystitis complicating bone marrow transplantation. Bone Marrow Transplant. 2002; 29:509-13.10.1038/sj.bmt.170341511960271
  44. 44. Erard V, Kim HW, Corey L, Limaye A, Huang ML, Myerson D, et al. BK DNA viral load in plasma: evidence for an association with hemorrhagic cystitis in allogeneic hematopoietic cell transplant recipients. Blood. 2005; 106:1130-2.10.1182/blood-2004-12-4988189516515845896
  45. 45. Hakki M, Riddell SR, Storek J, Carter RA, Stevens- Ayers T, Sudour P, et al. Immune reconstitution to cytomegalovirus after allogeneic hematopoietic stem cell transplantation: impact of host factors, drug therapy, and subclinical reactivation. Blood. 2003; 102: 3060-7.10.1182/blood-2002-11-3472
  46. 46. Azzi A, Cesaro S, Laszlo D, Zakrzewska K, Ciappi S, De Santis R, et al. Human polyomavirus BK (BKV) load and haemorrhagic cystitis in bone marrow transplantation patients. J Clin Virol. 1999; 14:79-86.10.1016/S1386-6532(99)00055-4
  47. 47. Bedi A, Miller CB, Hanson JL, Goodman S, AmbinderRF, Charache P, et al. Association of BK virus with failure of prophylaxis against hemorrhagic cystitis following bone marrow transplantation. J Clin Oncol. 1995; 13:1103-9.10.1200/JCO.1995.13.5.1103
  48. 48. Brugieres L, Hartmann O, Travagli JP, Benhamou E, Pico JL, Valteau D, et al. Hemorrhagic cystitis following high-dose chemotherapy and bone marrow transplantation in children with malignancies: incidence, clinical course, and outcome. J Clin Oncol. 1989; 7:194-9.10.1200/JCO.1989.7.2.194
  49. 49. Droller MJ, Saral R, Santos G. Prevention of cyclophosphamide-induced hemorrhagic cystitis. Urology. 1982; 20:256-8.10.1016/0090-4295(82)90633-1
  50. 50. Agostini HT, Brubaker GR, Shao J, Levin A, Ryschkewitsch CF, Blattner WA, et al. BK virus and a new type of JC virus excreted by HIV-1 positive patients in rural Tanzania. Arch Virol. 1995; 140: 1919-34.10.1007/BF01322682
  51. 51. Sundsfjord A, Flaegstad T, Flo R, Spein AR, Pedersen M, Permin H, et al. BK and JC viruses in human immunodeficiency virus type 1-infected persons: prevalence, excretion, viremia, and viral regulatory regions. J Infect Dis. 1994; 169:485-90.10.1093/infdis/169.3.485
  52. 52. Bratt G, Hammarin AL, Grandien M, Hedquist BG, Nennesmo I, Sundelin B, et al. BK virus as the cause of meningoencephalitis, retinitis and nephritis in a patient with AIDS. AIDS. 1999; 13:1071-5.10.1097/00002030-199906180-00010
  53. 53. Mouratoff JG, Tokumoto J, Olson JL, Chertow GM. Acute renal failure with interstitial nephritis in a patient with AIDS. Am J Kidney Dis. 2000; 35:557-61.10.1016/S0272-6386(00)70216-2
  54. 54. Nebuloni M, Tosoni A, Boldorini R, Monga G, Carsana L, Bonetto S, et al. BK virus renal infection in a patient with the acquired immunodeficiency syndrome. Arch Pathol Lab Med. 1999; 123:807-11.10.5858/1999-123-0807-BVRIIA10458828
  55. 55. Smith RD, Galla JH, Skahan K, Anderson P, Linnemann CC Jr, Ault GS, et al. Tubulointerstitial nephritis due to a mutant polyomavirus BK virus strain, BKV(Cin), causing end-stage renal disease. J Clin Microbiol. 1998; 36:1660-5.10.1128/JCM.36.6.1660-1665.19981048969620396
  56. 56. Markowitz RB, Thompson HC, Mueller JF, Cohen JA, Dynan WS. Incidence of BK virus and JC virus viruria in human immunodeficiency virus-infected and -uninfected subjects. J Infect Dis. 1993; 167:13-20.10.1093/infdis/167.1.138380288
  57. 57. Sundsfjord A, Osei A, Rosenqvist H, Van Ghelue M, Silsand Y, Haga HJ, et al. BK and JC viruses in patients with systemic lupus erythematosus: prevalent and persistent BK viruria, sequence stability of the viral regulatory regions, and nondetectable viremia. J Infect Dis. 1999; 180:1-9.10.1086/31483010353854
  58. 58. Marshall WF, Telenti A, Proper J, Aksamit AJ, Smith TF. Rapid detection of polyomavirus BK by a shell vial cell culture assay. J Clin Microbiol. 1990; 28: 1613-5. 10.1128/jcm.28.7.1613-1615.19902679982166090
  59. 59. Bogdanovic G, Priftakis P, Giraud G, Kuzniar M, Ferraldeschi R, Kokhaei P, et al. Association between a high BK virus load in urine samples of patients with graft-versus-host disease and development of hemorrhagic cystitis after hematopoietic stem cell transplantation. J Clin Microbiol. 2004; 42:5394-6.10.1128/JCM.42.11.5394-5396.200452518315528753
  60. 60. Leung AY, Suen CK, Lie AK, Liang RH, Yuen KY, Kwong YL. Quantification of polyoma BK viruria in hemorrhagic cystitis complicating bone marrow transplantation. Blood. 2001; 98:1971-8.10.1182/blood.V98.6.197111535537
  61. 61. Haririan A, Klassen D. BK virus infection after nonrenal transplantation. Graft. 2002; 5 (Suppl 1):S58-64. 10.1177/1522162802238458
  62. 62. Wong AS, Chan KH, Cheng VC, Yuen KY, Kwong YL, Leung AY. Relationship of pretransplantation polyoma BK virus serologic findings and BK viral reactivation after hematopoietic stem cell transplantation. Clin Infect Dis. 2007; 44:830-7.10.1086/51186317304456
  63. 63. Gorczynska E, Turkiewicz D, Rybka K, Toporski J, Kalwak K, Dyla A, et al. Incidence, clinical outcome, and management of virus-induced hemorrhagic cystitis in children and adolescents after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2005; 11:797-804.10.1016/j.bbmt.2005.06.00716182180
  64. 64. Randhawa PS, Vats A, Zygmunt D, Swalsky P, Scantlebury V, Shapiro R, et al. Quantitation of viral DNA in renal allograft tissue from patients with BK virus nephropathy. Transplantation. 2002; 74:485-8.10.1097/00007890-200208270-0000912352906
  65. 65. Bogdanovic G, Ljungman P, Wang F, Dalianis T. Presence of human polyomavirus DNA in the peripheral circulation of bone marrow transplant patients with and without hemorrhagic cystitis. Bone Marrow Transplant. 1996; 17:573-6.
  66. 66. Kranc DM, Kim J, Straus F, Levine LA. Prophylactic and therapeutic carboprost tromethamine bladder irrigation in rats with cyclophosphamide-induced hemorrhagic cystitis. J Urol. 1992; 148:1326-30.10.1016/S0022-5347(17)36902-1
  67. 67. Chan PK, Ip KW, Shiu SY, Chiu EK, Wong MP, Yuen KY. Association between polyomaviruria and microscopic haematuria in bone marrow transplant recipients. J Infect. 1994; 29:139-46.10.1016/S0163-4453(94)90602-5
  68. 68. Leung AY, Chan MT, Yuen KY, Cheng VC, Chan KH, Wong CL, et al. Ciprofloxacin decreased polyoma BK virus load in patients who underwent allogeneic hematopoietic stem cell transplantation. Clin Infect Dis. 2005; 40:528-37.10.1086/42729115712075
  69. 69. Drachenberg CB, Papadimitriou JC, Hirsch HH, Wali R, Crowder C, Nogueira J, et al. Histological patterns of polyomavirus nephropathy: correlation with graft outcome and viral load. Am J Transplant. 2004; 4: 2082-92.10.1046/j.1600-6143.2004.00603.x15575913
  70. 70. Ahuja M, Cohen EP, Dayer AM, Kampalath B, Chang CC, Bresnahan BA, et al. Polyoma virus infection after renal transplantation. Use of immunostaining as a guide to diagnosis. Transplantation. 2001; 71:896-9.10.1097/00007890-200104150-0001311349723
  71. 71. Mylonakis E, Goes N, Rubin RH, Cosimi AB, Colvin RB, Fishman JA. BK virus in solid organ transplant recipients: an emerging syndrome. Transplantation. 2001; 72:1587-92.10.1097/00007890-200111270-0000111726814
  72. 72. Andrews CA, Shah KV, Daniel RW, Hirsch MS, Rubin RH. A serological investigation of BK virus and JC virus infections in recipients of renal allografts. J Infect Dis. 1988; 158:176-81.10.1093/infdis/158.1.1762839580
  73. 73. Ding R, Medeiros M, Dadhania D, Muthukumar T, Kracker D, Kong JM, et al. Noninvasive diagnosis of BK virus nephritis by measurement of messenger RNA for BK virus VP1 in urine. Transplantation. 2002; 74: 987-94.10.1097/00007890-200210150-0001612394843
  74. 74. Brennan DC, Agha I, Bohl DL, Schnitzler MA, Hardinger KL, Lockwood M, et al. Incidence of BK with tacrolimus versus cyclosporine and impact of preemptive immunosuppression reduction. Am J Transplant. 2005; 5:582-94.10.1111/j.1600-6143.2005.00742.x15707414
  75. 75. Drachenberg CB, Hirsch HH, Ramos E, Papadimitriou JC. Polyomavirus disease in renal transplantation: review of pathological findings and diagnostic methods. Hum Pathol. 2005; 36:1245-55.10.1016/j.humpath.2005.08.00916311117
  76. 76. Limaye AP, Jerome KR, Kuhr CS, Ferrenberg J, Huang ML, Davis CL, et al. Quantitation of BK virus load in serum for the diagnosis of BK virus-associated nephropathy in renal transplant recipients. J Infect Dis. 2001; 183:1669-72.10.1086/32071111343217
  77. 77. Comoli P, Binggeli S, Ginevri F, Hirsch HH. Polyomavirus-associated nephropathy: update on BK virus-specific immunity. Transpl Infect Dis. 2006; 8: 86-94.10.1111/j.1399-3062.2006.00167.x16734631
  78. 78. Held TK, Biel SS, Nitsche A, Kurth A, Chen S, Gelderblom HR, et al. Treatment of BK virus-associated hemorrhagic cystitis and simultaneous CMV reactivation with cidofovir. Bone Marrow Transplant. 2000; 26:347-50.10.1038/sj.bmt.170248710967578
  79. 79. Kawakami M, Ueda S, Maeda T, Karasuno T, Teshima H, Hiraoka A, et al. Vidarabine therapy for virusassociated cystitis after allogeneic bone marrow transplantation. Bone Marrow Transplant. 1997; 20: 485-90.10.1038/sj.bmt.17009239313882
  80. 80. Randhawa PS, Demetris AJ. Nephropathy due to polyomavirus type BK. N Engl J Med. 2000; 342: 1361-3. 10.1056/NEJM20000504342180910793170
  81. 81. Mayr M, Nickeleit V, Hirsch HH, Dickenmann M, Mihatsch MJ, Steiger J. Polyomavirus BK nephropathy in a kidney transplant recipient: critical issues of diagnosis and management. Am J Kidney Dis. 2001; 38:E13.10.1053/ajkd.2001.2691711532715
  82. 82. Andrei G, Snoeck R, Vandeputte M, De Clercq E. Activities of various compounds against murine and primate polyomaviruses. Antimicrob Agents Chemother. 1997;41:587-93.10.1128/AAC.41.3.5871637569055998
  83. 83. Randhawa P, Farasati NA, Shapiro R, Hostetler KY. Ether lipid ester derivatives of cidofovir inhibit polyomavirus BK replication in vitro. Antimicrob Agents Chemother. 2006; 50:1564-6.10.1128/AAC.50.4.1564-1566.2006142694216569886
  84. 84. Kadambi PV, Josephson MA, Williams J, Corey L, Jerome KR, Meehan SM, et al. Treatment of refractory BK virus-associated nephropathy with cidofovir. Am J Transplant. 2003; 3:186-91.10.1034/j.1600-6143.2003.30202.x12614296
  85. 85. Williams JW, Javaid B, Kadambi PV, Gillen D, Harland R, Thistlewaite JR, et al. Leflunomide for polyomavirus type BK nephropathy. N Engl J Med. 2005; 352:1157-8.10.1056/NEJM20050317352112515784677
  86. 86. Josephson MA, Gillen D, Javaid B, Kadambi P, Meehan S, Foster P, et al. Treatment of renal allograft polyoma BK virus infection with leflunomide. Transplantation. 2006; 81:704-10.10.1097/01.tp.0000181149.76113.50
  87. 87. Chapman C, Flower AJ, Durrant ST. The use of vidarabine in the treatment of human polyomavirus associated acute haemorrhagic cystitis. Bone Marrow Transplant. 1991; 7:481-3.
  88. 88. Dropulic LK, Jones RJ. Polyomavirus BK infection in blood and marrow transplant recipients. Bone Marrow Transplant. 2008; 41:11-8.10.1038/sj.bmt.1705886
  89. 89. Gonzalez-Fraile MI, Canizo C, Caballero D, Hernandez R, Vazquez L, Lopez C, et al. Cidofovir treatment of human polyomavirus-associated acute haemorrhagic cystitis. Transpl Infect Dis. 2001; 3:44-6.10.1034/j.1399-3062.2001.003001044.x
  90. 90. Barouch DH, Faquin WC, Chen Y, Koralnik IJ, Robbins GK, Davis BT. BK virus-associated hemorrhagic cystitis in a Human Immunodeficiency Virus-infected patient. Clin Infect Dis. 2002; 35:326-9.10.1086/341491
  91. 91. Fanourgiakis P, Georgala A, Vekemans M, Triffet A, De Bruyn JM, Duchateau V, et al. Intravesical instillation of cidofovir in the treatment of hemorrhagic cystitis caused by adenovirus type 11 in a bone marrow transplant recipient. Clin Infect Dis. 2005; 40:199-201.10.1086/426594
  92. 92. Bridges B, Donegan S, Badros A. Cidofovir bladder instillation for the treatment of BK hemorrhagic cystitis after allogeneic stem cell transplantation. Am J Hematol. 2006; 81:535-7.10.1002/ajh.20567
  93. 93. Portolani M, Pietrosemoli P, Cermelli C, Mannini- Palenzona A, Grossi MP, Paolini L, et al. Suppression of BK virus replication and cytopathic effect by inhibitors of prokaryotic DNA gyrase. Antiviral Res. 1988; 9:205-18.10.1016/0166-3542(88)90004-6
  94. 94. Gine E, Rovira M, Real I, Burrel M, Montana J, Carreras E, et al. Successful treatment of severe hemorrhagic cystitis after hemopoietic cell transplantation by selective embolization of the vesical arteries. Bone Marrow Transplant. 2003; 31:923-5.10.1038/sj.bmt.170395412748670
  95. 95. Ginevri F, De Santis R, Comoli P, Pastorino N, Rossi C, Botti G, et al. Polyomavirus BK infection in pediatric kidney-allograft recipients: a single-center analysis of incidence, risk factors, and novel therapeutic approaches. Transplantation. 2003; 75:1266-70.10.1097/01.TP.0000061767.32870.7212717214
  96. 96. Randhawa P, Zygmunt D, Shapiro R, Vats A, Weck K, Swalsky P, et al. Viral regulatory region sequence variations in kidney tissue obtained from patients with BK virus nephropathy. Kidney Int. 2003; 64: 743-7.10.1046/j.1523-1755.2003.00132.x12846774
  97. 97. Trofe J, Gaber LW, Stratta RJ, Shokouh-Amiri MH, Vera SR, Alloway RR, et al. Polyomavirus in kidney and kidney-pancreas transplant recipients. Transpl Infect Dis. 2003; 5:21-8.10.1034/j.1399-3062.2003.00009.x
  98. 98. Knowles WA, Pillay D, Johnson MA, Hand JF, Brown DW. Prevalence of long-term BK and JC excretion in HIV-infected adults and lack of correlation with serological markers. J Med Virol. 1999; 59:474-9.10.1002/(SICI)1096-9071(199912)59:4<;474::AID-JMV9>3.0.CO;2-W
  99. 99. Childs R, Sanchez C, Engler H, Preuss J, Rosenfeld S, Dunbar C, et al. High incidence of adeno- and polyomavirus-induced hemorrhagic cystitis in bone marrow allotransplantation for hematological malignancy following T cell depletion and cyclosporine. Bone Marrow Transplant. 1998; 22:889-93.10.1038/sj.bmt.1701440
  100. 100. Randhawa PS, Finkelstein S, Scantlebury V, Shapiro R, Vivas C, Jordan M, et al. Human polyoma virusassociated interstitial nephritis in the allograft kidney. Transplantation. 1999; 67:103-9.10.1097/00007890-199901150-00018
DOI: https://doi.org/10.2478/abm-2010-0002 | Journal eISSN: 1875-855X | Journal ISSN: 1905-7415
Language: English
Page range: 3 - 18
Published on: Apr 13, 2018
Published by: Chulalongkorn University
In partnership with: Paradigm Publishing Services
Publication frequency: 6 times per year

© 2018 Chakrapol Sriaroon, John N. Greene, Albert L. Vincent, Veronica T. Tucci, Mohamed A. Kharfan-Dabaja, Ramon Sandin, published by Chulalongkorn University
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.